Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Matthew W. Foehr | CLO & Secretary, Director | Nov 1, 2022 | |||
Kurt A. Gustafson | EVP, Finance and CFO | Nov 1, 2022 | |||
Ligand Pharmaceuticals Inc | 10%+ Owner | Nov 1, 2022 | |||
Charles S. Berkman | CLO & Secretary, Director | Nov 1, 2022 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|